TP53 and neoplasm: In terms of clinical and molecular characteristics, the two clusters differ significantly, suggesting the existence of two groups of CRCs: cluster 1, presenting with prominent chromosomal instability, distal tumor localization, and high TP53 and APC mutation rates, and cluster 2, with a high mutation rate, proximal tumor localization, and microsatellite instability.